DSS TheraDoc Supported COVID-19 Monoclonal Antibody Infusions Workflow at a Veterans Affairs Medical Center

At ID Week 2022, VA executives presented a poster session titled, highlighting how high-risk patients with mild to moderate disease were identified as a group who would benefit from COVID-19 monoclonal antibody (mAB) treatment to mitigate progression to severe disease or hospitalization.

Read More
DSS TheraDoc Helps Battle Super Bugs for Better Veteran Health

Strong renewal rates show that TheraDoc is fighting “super bugs” and supporting better Veteran care

Read More
PODCAST: Making Strides Against Veterans Suicide

Michele Burst, Director Strategic Innovations, Analytics at DSS, Inc., was a guest on the FedHealthIT “Keeping It Brief” podcast, where she discussed the company’s Mission Daybreak submission, and how DSS is a catalyst for care innovation for the VA.

Read More
PODCAST: DSS Inc. is a Catalyst for Health Care Innovation in Federal and Commercial Arenas

Rodney Neal, CRO and VP, Sales & Marketing at DSS, Inc., discusses the current and future state of digital transformation in health care IT, and how DSS, Inc. is a true innovation catalyst for the federal and commercial arenas.

Read More
DSS, Inc. Presenting Real-time, Performance Measure Driven Veteran Suicide Prevention at the AMIA 2022 Annual Symposium

At the AMIA 2022 Annual Symposium, Dr. David LaBorde, CEO, Iconic Data, Inc. and senior advisor to DSS will be presenting about real-time, performance measure driven suicide prevention.

Read More